NDC codes

382549 NDC codes with hospital pricing data in the network.

• NDC 60219205601 — DEXAMETHASONE 2 MG TABLET (54 hospitals, 4,268–5,177 samples)
• NDC 16729-0288-11 — CISPLATIN 1 MG/ML INTRAVENOUS SOLUTION (68 hospitals, 5,107–5,170 samples)
• NDC 00270131415 — IOPAMIDOL 200 MG IODINE/ML (41 %) INTRAVENOUS SOLUTION [27736] (42 hospitals, 4,395–5,169 samples)
• NDC 00409469933 — PROPOFOL 500 MG-50ML IV EMUL (189 hospitals, 3,557–5,168 samples)
• NDC 65219-0383-05 — IODIXANOL 320MG/ML 50ML (20 hospitals, 4,997–5,168 samples)
• NDC 39822303001 — PENTAMIDINE 300 MG SOLUTION FOR INHALATION (81 hospitals, 4,128–5,163 samples)
• NDC 59762-5050-07 — GABAPENTIN 250 MG/5 ML ORAL SOLUTION (23 hospitals, 4,870–5,158 samples)
• NDC 63323-0314-61 — VANCOMYCIN 500MG(10GM)MDV (92 hospitals, 4,915–5,149 samples)
• NDC 70092144343 — LIDOCAINE 0.9 % BUFFERED WITH 8.4 % SODIUM BICARB (1 ML) INJ SYRINGE (84 hospitals, 4,422–5,142 samples)
• NDC 76045001001 — NDC Description Not Available (73 hospitals, 2,035–5,140 samples)
• NDC 25021-0608-51 — PROPOFOL 10 MG/ML INTRAVENOUS EMULSION (68 hospitals, 4,427–5,138 samples)
• NDC 00173087414 — FLUTICASONE FUROATE 100 MCG/ACTUATION BLISTER POWDER FOR INHALATION (176 hospitals, 4,180–5,134 samples)
• NDC 00054818325 — DEXAMETHASONE 6 MG TABLET (101 hospitals, 4,241–5,132 samples)
• NDC 72572-0170-01 — NAFCILLIN IN DEXTROSE ISO-OSM 2 GRAM/100 ML IV PGBK (30 hospitals, 4,894–5,128 samples)
• NDC 76045000911 — HYDROMORPHONE HCL 1 MG/ML INJECTION SOLN (234 hospitals, 2,693–5,123 samples)
• NDC 60267070550 — SODIUM THIOSULFATE 12.5 GRAM/50 ML (250 MG/ML) INTRAVENOUS SOLUTION (400 hospitals, 1,359–5,121 samples)
• NDC 67457043710 — doxycycline hyclate 10 mg/mL INJ 10 mL (149 hospitals, 4,373–5,120 samples)
• NDC 00597010051 — TIOTROPIUM BROMIDE 2.5 MCG/ACTUATION MIST FOR INHALATION (186 hospitals, 4,171–5,116 samples)
• NDC 50419032518 — GADOBUTROL 1 MMOL/ML IV SOLN (WRAPPED RECORD) (33 hospitals, 4,340–5,105 samples)
• NDC 50419032514 — GADOBUTROL 1 MMOL/ML (604.72 MG/ML) INTRAVENOUS SOLUTION [109395] (63 hospitals, 4,340–5,105 samples)
• NDC 00338-9159-30 — SODIUM CHLORIDE 0.9 % INTRAVENOUS PIGGYBACK (59 hospitals, 4,969–5,104 samples)
• NDC 70092154635 — HYDROMORPHONE 1 MG/ML SOLUTION (98 hospitals, 4,373–5,102 samples)
• NDC 58160-0842-11 — BOOSTRIX/TDAP 0.5ML (78 hospitals, 3,369–5,097 samples)
• NDC 00517-2340-01 — IRON SUCROSE 100 MG IRON/5 ML INTRAVENOUS SOLUTION (106 hospitals, 4,960–5,095 samples)
• NDC 00487900360 — NDC Description Not Available (138 hospitals, 4,843–5,095 samples)
• NDC 69374095610 — PHENYLEPHRINE 0.8 MG/10 ML (80 MCG/ML) IN 0.9 %SOD.CHLORIDE IV SYRINGE (26 hospitals, 4,372–5,092 samples)
• NDC 70092148443 — LIDOCAINE 0.9 % BUFFERED WITH 8.4 % SODIUM BICARB (1 ML) INJ SYRINGE (20 hospitals, 4,372–5,092 samples)
• NDC 09991251300 — PHENYLEPHRINE 2.5%/TROPICAMINE 0.25%/DICLOFENAC 0.05% OPHTH SOLN (20 hospitals, 4,372–5,092 samples)
• NDC 00069-1340-05 — INJECTION, ONDANSETRON HYDROCHLORIDE, PER 1 MG (17 hospitals, 4,572–5,085 samples)
• NDC 63323085303 — HYDROMORPHONE (PF) 2 MG/ML INJECTION SOLUTION (167 hospitals, 1,845–5,085 samples)
• NDC 25021040010 — 25021-0400-10 - heparin 10000. Soln (275 hospitals, 941–5,081 samples)
• NDC 59746017306 — VENLAFAXINE HCL 37.5 MG PO TABS (134 hospitals, 3,929–5,081 samples)
• NDC 00409765005 — HEPARIN (PORCINE) 100 UNIT/ML IN 0.45 % SODIUM CHLORIDE INFUSION 50 ML (PEDI BCH-SF) (126 hospitals, 576–5,067 samples)
• NDC 00173086906 — ANORO ELLIPTA 62.5-25 MCG-ACT IN AEPB (245 hospitals, 4,242–5,061 samples)
• NDC 00173071820 — Flovent Hfa: 1 Inhaler In 1 Carton (0173-0718-20) / 120 Aerosol, Metered In 1 Inhaler (106 hospitals, 4,165–5,056 samples)
• NDC 00173071920 — FLOVENT HFA (120 hospitals, 4,165–5,056 samples)
• NDC 00173072020 — FLUTICASONE PROPIONATE 220 MCG/ACTUATION HFA AEROSOL INHALER (112 hospitals, 4,165–5,056 samples)
• NDC 59746017210 — PREDNISONE 5 MG PO TABS (29 hospitals, 3,926–5,051 samples)
• NDC 00338-0049-31 — SODIUM CHLORIDE 0.9 % IV BOLUS (43 hospitals, 3,245–5,045 samples)
• NDC 00003-3756-14 — NIVOLUMAB 120 MG/12 ML INTRAVENOUS SOLUTION (81 hospitals, 4,855–5,044 samples)
• NDC 63323066005 — METOPROLOL TARTRATE 5 MG-5ML IV SOLN (154 hospitals, 4,518–5,040 samples)
• NDC 00270-1316-41 — IOPAMID 370MG/ML 100MLINJ (9 hospitals, 4,747–5,026 samples)
• NDC 63323006443 — MAGNESIUM SULFATE 500 MG/ML (50 %) INJECTION SOLUTION (113 hospitals, 2,209–5,026 samples)
• NDC 71139603001 — FENTANYL DRIP 50 MCG/ML > 20 KG PEDS/ADULTS (9 hospitals, 813–5,016 samples)
• NDC 00009-4709-13 — Depo-SubQ Provera 104 (13 hospitals, 4,960–5,014 samples)
• NDC 55150012502 — ondansetron 4 mg/2 mL Soln-Inj (162 hospitals, 4,411–5,005 samples)
• NDC 00009003932 — SOLU-MEDROL (PF) 40 MG/ML IJ SOLR (91 hospitals, 3,176–5,003 samples)
• NDC 65219038310 — IODIXANOL 320 MG/ML IV SOLN (74 hospitals, 4,353–5,001 samples)
• NDC 69097-0008-22 — NICARDIPINE HCL IN NACL 40-0.9 MG/200ML-% IV SOLN (13 hospitals, 5,000 samples)
• NDC 00186037228 — Symbicort 80/4.5 (241 hospitals, 4,135–4,999 samples)